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ABSTRACT
The GPCRDB is a Molecular Class-Specific
Information System (MCSIS) that collects,
combines, validates and disseminates large
amounts of heterogeneous data on G protein-
coupled receptors (GPCRs). The GPCRDB contains
experimental data on sequences, ligand-binding
constants, mutations and oligomers, as well as
many different types of computationally derived
data such as multiple sequence alignments and
homology models. The GPCRDB provides access
to the data via a number of different access
methods. It offers visualization and analysis tools,
and a number of query systems. The data is
updated automatically on a monthly basis. The
GPCRDB can be found online at http://www.gpcr
.org/7tm/.
INTRODUCTION
G protein-coupled receptors (GPCRs) constitute a large
family of cell surface receptors. They regulate a wide range
of cellular processes, including the senses of taste, smell
and vision, and control a myriad of intracellular signaling
systems in response to external stimuli. GPCRs are a
major target for the pharmaceutical industry as is reﬂected
by the fact that more than a quarter of all FDA approved
drugs act on a GPCR (1). GPCRs are arguably one of the
most-researched classes of proteins, but despite intensive
academic and industrial research efforts over the past
three decades, little is known about the structural basis
of GPCR function. From about 350 genes that code for
the non-olfactorial receptors in the human species (2),
only about 30 are truly validated therapeutic targets (3),
indicating this family’s immense potential for future
drug development. The fact that GPCRs can form
homo-oligomeric and hetero-oligomeric complexes (4)
has created a lot of new challenges and opportunities in
the rational drug design process. In addition, a number of
high-resolution crystal structures recently became avail-
able, providing new insights in receptor structure and
function and giving the GPCR ﬁeld a big stimulus.
Researchers who focus on one particular protein or
a class of proteins are confronted with the fact that both
the number and the size of databases are expanding at an
ever-increasing pace. Although many databases like PDB
(5), UniProtKB (6), KEGG (7), EMBL (8), GenBank (9),
etc. are invaluable for their research, for the average
wet-lab scientist these databases are less suitable for
gathering, integrating, and updating different types of
data in an easy and efﬁcient manner. Studies that
involve carrying over information from one protein to
the other seem simple at a ﬁrst glance, however, the
amount of data that needs to be collected from hetero-
geneous sources, converted to syntactic and semantic
homogeneity, validated, curated, stored and indexed, is
enormous.
The GPCRDB is a data source that holds a large
amount of heterogeneous data in a well-organized and
easily accessible form. This data is validated, internally
consistent, and updated regularly. In addition to being a
one-stop GPCR resource, the data in the GPCRDB facili-
tates inferring new information using a wide spectrum of
bioinformatics techniques. The GPCRDB is a paradigm
for MCSIS technology (10,11).
NEW FEATURES
The previous release of the GPCRDB (12) was almost
entirely a static website, neither offering much dynamic
content, nor possibilities for complex interactions or
the use of computational tools. We addressed this
problem by rewriting the entire system. The use of new
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in improved ﬂexibility and greater user-friendliness.
We have updated the methods for harvesting GPCR
sequences, expanded the number of data types available,
and added new tools and services to the GPCRDB. Nearly
all of the functionality that is offered through the web
interface is also available in the form of web services.
This allows for the easy integration of the GPCRDB in
custom built tools and scripts or in workﬂow management
tools such as Taverna (13) and Pipeline Pilot (http://www
.accelrys.com/products/pipeline-pilot/). All pages now
offer extensive context-sensitive help functionality,
explaining what kinds of data are displayed and how
to use the available interactive functionalities such as
searching and computational tools.
DATA CONTENT
The contents of the GPCRDB can be categorized in three
classes: primary, secondary and tertiary data. Sequence
data, ligand-binding constants, mutant information,
structural data and oligomer interactions make up the
experimentally determined primary data. Data types
such as multiple sequence alignments (MSAs), homology
models, correlation patterns and entropy-variability data
are inferred from these primary data, and fall in the
category of secondary, or computationally derived data.
Curator provided interpretations and other user help
facilities make up the tertiary data category. Table 1
shows a few vital statistics about the volume of the data
content of the GPCRDB.
PRIMARY DATA
Sequences
GPCR sequences are extracted from NCBI’s NR database,
which is a non-redundant protein sequence database
with entries from a set of sequence repositories that
include GenBank CDS translations, UniProtKB and
PDB. GPCR sequences are selected by classifying
them against a database of Hidden Markov Models
(HMMs). For each of the protein families in the
GPCRDB a HMM is available. These HMMs are created
from MSA of the previous GPCRDB release. HMM
ﬁles are created with the HMMER software package
(http://hmmer.wustl.edu/).
As a ﬁrst step in harvesting GPCR sequences we
perform a BLAST search with all the HMM consensus
sequences against the NR database. By using a very
relaxed cut-off value we collect a large number of resulting
hits, including many false positives. This step is necessary
to limit the amount of sequences that will be used for the
actual classiﬁcation while ensuring a minimal false-
negative rate. This step reduced the search space (for the
September 2010 GPCRDB release) from about 11 million
sequences to about 80000. These hits are scored against
the collection of HMMs to place them in the correct
family or discard them as not being a GPCR sequence.
Additional ﬁlter steps are applied such as ﬁltering
out sequence fragments and sequences that contain
ambiguous amino acid characters, resulting in a ﬁnal set
of about thirty thousand sequences. The corresponding
database entries of the selected sequences are retrieved
with MRS (14) and additional data such as gene names
and species information is extracted and stored. The
GPCRDB holds for each sequence one principal access
page. Figure 1 shows an example of such a page.
The protein detail page (Figure 1) contains a panel that
visualizes sequence annotations such as helix boundaries,
cysteine bridges and glycosylation sites. These annotations
are loaded in real time using the DAS distributed annota-
tion system (15,16) and are visualized by Dasty2 (17),
resulting in always up-to-date annotations. We use the
UniProt DAS server to retrieve sequence annotations.
Ligand-binding data
Ligand-binding constants are available for a large number
of GPCRs and are obtained from various sources. For
each GPCR we provide links, if possible, to the
ChEMBL (18) and GLIDA (19) databases. In addition,
ligand-binding information that is obtained from collec-
tions from Seeman (20) and Organon (21) is available.
Since ligand-binding data is very hard to obtain from
the literature we encourage academic and industrial
researchers to submit their ligand-binding data to the
GPCRDB in order to make this data accessible to the
scientiﬁc community.
Mutations
The GPCRDB contains a large number of well-annotated
mutations obtained from different sources. We have two
sets of mutations that were manually extracted from lit-
erature. Mutant data from the tinyGRAP database (22)
contains references to scientiﬁc literature describing point
mutations as well as insertions, deletions and chimeric re-
ceptors. A collection of in-house manually extracted
mutant data contains a few thousand point mutations
and the effects of those mutations on the function of the
receptor. We have extracted sentences from the papers
that qualitatively describe the effects of these mutation
and we have extracted quantitative data such as effects
on ligand binding, expression, activation or constitutive
activity.
In addition to the two manually curated data sets we
also have a large body of mutations that were extracted
from the literature by the software package MuteXt (23).
A sentence describing the effects of the mutations is avail-
able for all mutations extracted by MuteXt.
Table 1. Statistics for the September 2010 release of the GPCRDB
Sequences 27045
Families (and MSA) 1270
Mutations 7703
Ligand-binding data 12086
Protein structures 195
Homology models 22616
Residues 11290993
Species 1521
Oligomers 115
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Structures are obtained from the PDB. Links to structures
that were re-reﬁned in the PDB_REDO project (24) are
included. We provide manually ‘cleaned’ monomers of the
major GPCR PDB ﬁles that have been prepared for easy
casual use by the life sciences community.
Oligomers
GPCR oligomerization has been an area of interest and
controversy for many years. Recently there has been
increasing evidence that both homo-dimers and hetero-
dimers play a crucial role in GPCR signaling (25–27).
The GPCR-OKB (28) is a database that stores manually
extracted computational and experimental information
about GPCR oligomerization. Lists of protomers, experi-
mental details and, where available, inferred oligomer
interaction sites are available for all oligomers. This data
has been fully integrated in the GPCRDB, making the
information about both GPCR protomers and oligomers
readily available.
Figure 1. Screenshot of the principal protein sequence page of the human beta-2 adrenoceptor. The top table contains details about the protein
record and hyperlinks to the protein family browsing page and other data sources that contain information about this protein. The middle table
holds the sequence in which each amino acid is linked to its own residue page. The bottom table holds annotations that are obtained in real time
using the DAS (15) system.
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Multiple sequence alignments
MSAs are available for all families. MSAs are generated
with WHAT IF (29) for all GPCR sub-families using
hand-optimized sub-family speciﬁc proﬁles. Position-
speciﬁc annotations such as secondary structure informa-
tion and generalized residue numbers are stored in the
proﬁles and are incorporated in the alignments. The
general residue numbers are relative to the arbitrarily
selected numbers for very conserved residues and motifs
such as the well-known E/DRY and NPXXY motifs.
Using a proﬁle to align a GPCR sub-family allows for
the mapping of the general residue numbers on the
sequences that are being aligned. The result is that the
residues in the TM domains, helix VIII and sections of
the loops are labeled with a general residue number.
For creating alignments of parent GPCR families we
make use of these general residue numbers. For all the
GPCRs that are being aligned we select all the general
residue positions that the sub-families have in common
and create the alignment by listing, for each sequence,
the residues at the selected positions. GPCR parent
family alignments are thus not built using standard align-
ment algorithms but are created by selecting residues that
are likely to share the same position in the 3D structure.
Homology models
Despite the recent publication of a number of GPCR
structures the amount of structural information on
GPCRs is still very limited. We have built structure
models of all Class A receptors to at least partially ﬁll
this gap. Information extracted from the proﬁle-based
MSA is used to generate high-quality sequence–structure
alignments between GPCR sequences and a number of
experimentally determined structures. Based on these
alignments homology models of all GPCRs have been
automatically created and will be automatically updated
as more sequences become available. Template structures
are selected based on sequence identity and a number of
structure quality criteria. The homology models are
created with WHAT IF and YASARA (30). Models will
be automatically replaced when new structures become
available that are better templates, with better being
deﬁned as either being solved with higher resolution
data, or as having a higher percentage sequence identity.
Correlated mutation analyses
Correlated mutation analysis (CMA) is a technique that
can ﬁnd pairs of residues that remain conserved or mutate
in tandem during evolution. Residues that show correlated
behaviour in MSA are likely to be functionally related,
and networks of those correlating residues indicate func-
tional groups (31). The rationale behind this analysis is
that when a mutation occurs at a functionally important
site, the protein either becomes functionally impaired or
may acquire its original or a different function due to
compensatory mutations at one or more other positions.
Correlation scores are available in a number of different
formats for all GPCR (sub)families.
Entropy and variability data
The amount of entropy and variability that is observed for
a certain position in multiple sequence alignment tells
something about the types of pressures exerted on that
position during evolution (32–34). Entropy-variability
data is available for each multiple sequence alignment in
the GPCRDB. We offer this data in tabular from,
entropy-variability plots (35), and more advanced sub-
family speciﬁc two-entropy plots (manuscript in prepar-
ation) based on the original method described by Ye et al.
(36) (Figure 2).
TERTIARY DATA
Residue annotations
Residues in the GPCRDB are labelled with the original
Oliveira et al. (37) numbering scheme as well as with
residue numbers from the more recent Ballesteros–
Weinstein scheme. Use of these general residue numbers
allows for easy transfer of information between proteins.
General residue numbers are available for all residues
within conserved structure elements. These include all
transmembrane helices, helix VIII and a few sections in
the loops. For each residue with a general residue number
a short description of its properties and interactions is
available. These descriptions are based on a manual
analysis of the currently available crystal structures.
Cytoscape networks
The GPCRDB provides cytoscape (38) network ﬁles for
all GPCR families. These network ﬁles contain the
proteins of a family with distances calculated from the
family alignments. For all proteins the protein family in-
formation, species names and the amino acid types for all
the residues annotated with a general residue number are
available as attributes. This allows for complex analyses,
such as coloring proteins by amino acids at a certain
residue position to compare i.e. species or sub-type
speciﬁc differences.
Mutation predictions
For all positions for which a general residue number is
available we have investigated the most likely effects of
mutations at these positions. Short fragments of text
have been created that explain for each of these positions
the likely effects of the mutation on structural and func-
tional levels. References to key papers in which experi-
mental evidence for these effects is available are included
in the fragments. Examples of such effects are the loss of
ligand-binding afﬁnity when mutating a residue in the
ligand-binding pocket, the loss of G protein binding
when mutating residues at the G protein-binding interface,
and increased constitutive activity when residues are
mutated a the interface between helix III and VI.
Workﬂows
We have created a number of Taverna workﬂows that use
the web services of the GPCRDB as a starting point for
users who want to programmatically access the GPCRDB.
D312 Nucleic AcidsResearch, 2011, Vol.39, Database issueWorkﬂows are available that use the GPCRDB BLAST
service, create custom-built alignments and retrieve several
different data types. The workﬂows and documentation
are available via the myExperiment web portal (39) and
are tagged with ‘GPCRDB’. We encourage researchers to
share their own workﬂows via the myExperiment portal.
DATA ACCESS
The GPCRDB provides fast and easy access to all its data
and information. The GPCRDB does not merely lists
available data, but all data types are fully integrated.
For example, mutations are accessible via the protein
detail pages but can also be found at the residue level.
The same holds true for oligomer interaction interfaces,
where details about these interactions are available via
the oligomer pages, but also via the protein detail pages
of interacting members, as well as via the pages of residues
that are reported in the interaction. This tight data
integration makes it a very efﬁcient resource to use.
The GPCRDB’s user interface allows the user to easily
navigate from one data type to another and often
suggests multiple routes to explore the data, thereby
hopefully generating ideas and questions while the user
navigates the system.
The four fundamental facilities to be provided by infor-
mation systems are browsing, retrieval, query and
inferencing. These four types of access have been an
integral part of the GPCRDB set-up from the beginning.
The total redesign of the GPCRDB that has taken place
the past few years has allowed us to add novel access
facilities in all these four categories.
Browsing
The main way to access the data is via a hierarchical list of
GPCR families, which is based on the pharmacological
classiﬁcation of GPCRs (40) (Figure 3). Users can
traverse the GPCR family tree and view or download
the data for a selected family. Available data types
include MSAs, entropy-variability analyses and lists of
family members. Alignments can be viewed in multiple
Figure 2. Screenshot of the interactive entropy and variability page. The multiple sequence alignment is shown in (A). Residues are interlinked in all
page elements, clicking results in highlighted selections. In (B), the approximate location of this position in the 3D model of the transmembrane
domain of class A GPCRs is shown in red and is annotated with general residue number information. The orange ball in the structure model
indicates the approximate location of the assumed binding site for low molecular weight compounds of class A GPCRs. In (C) the user can choose
among four display modes that describe the entropy and variability of all positions in the alignment; shown is the entropy cluster variant.
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GPCRDB offers an interactive multiple sequence align-
ment viewer [JalView (41)], that can show additional in-
formation about the MSAs, supports a number of viewing
and sorting options, and that can be used to generate
phylogenetic trees. Residues for which mutation data is
available are hyperlinked in the alignments to pages that
contain more details about those mutations.
The pages that display data on individual proteins
(Figure 1) contain a large amount of data and links to
other data sources. Table 2 lists the remote databases
that have been indexed in the GPCRDB. Some of these
remote data are actually most easily queried via the
GPCRDB.
On the protein detail page the sequence is displayed and
each residue is hyperlinked to its individual page where
additional information is listed about that speciﬁc residue;
residue numbers in multiple numbering schemes, available
mutation data for that speciﬁc residue and mutations at
equivalent positions, and reported oligomeric interactions.
Snake plots are available for all proteins in the
GPCRDB (Figure 4). Residues for which mutations are
available are hyperlinked from the snake plots to pages
that contain details about those mutations.
Other data types such as mutations, ligand-binding
constants and information about oligomerization states
are displayed when available and links are provided to
pages that contain more detailed information about
those data (Figure 5).
The pages with mutation details contain links to the
scientiﬁc literature and if available in that literature,
the qualitative and quantitative data on the effects of
Figure 3. Screenshot of the GPCR family page. The GPCR family tree is shown on the left with the amine sub-family expanded. On the right-hand
side the data for the selected family (adrenoceptors) is shown.
Table 2. Non-GPCRDB data facilities that can be found through the GPCRDB
Database Type of data Address
GPCR-OKB (GPCR oligomerization knowledge base) Dimer information http://data.gpcr-okb.org/gpcr-okb/
GPCRRD (GPCR restraint database) Modeling restraints http://zhanglab.ccmb.med.umich.edu/GPCRRD/
GLIDA (GPCR ligand database) Ligand data http://pharminfo.pharm.kyoto-u.ac.jp/services/glida/
gpDB (G protein database) G Protein data http://biophysics.biol.uoa.gr/gpDB/
UniProt Protein information http://www.uniprot.org/
NAVA Sequence Variants http://nava.liacs.nl/
ChEMBL Ligand data http://www.ebi.ac.uk/chembl/
Ensembl Genomic information
and annotations
http://www.ensembl.org
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contains links to the GPCR-OKB and to the individual
protomers in the GPCRDB. If certain residues are
involved in the oligomer interaction, hyperlinks to indi-
vidual residue pages are available.
Retrieval
Data can be retrieved via the web pages and via the web
services. The web services offer very extensive retrieval
possibilities, together allowing for the retrieval of all
data types present in the GPCRDB. Subsets have been
Figure 5. Screenshot of the detail page of residue W175 in OPSD_HUMAN. Residue numbers in different formats are shown, the approximate
location of the residue is visually indicated and available mutations and oligomer data for this residue are listed.
Figure 4. Snake plot of the human b2 adrenoceptor.
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human sequences and the human non-olfactory sequences.
Protein family alignments can be downloaded in a number
of different formats. Sequences, structures, ligand-binding
data and mutations can be downloaded from the protein
detail pages. After querying the GPCRDB via the
web pages, query result sets can be downloaded in
FASTA format. A complete copy of the GPCRDB
is freely available for in-house usage by academic and
industrial researchers alike.
Query
Users can query the GPCRDB via a number of different
search pages. Identiﬁers, genes, species, descriptions and
protein family names can be used to search for GPCRs
(Figure 6). There are a number of ﬁlters available to
limit the search results. Users can indicate whether only
GPCRs should be shown for which mutations, structures,
oligomers, or ligand-binding data are available.
Mutations can be found via the mutant search page,
where one can search by residue number (multiple num-
bering schemes are available) and/or residue types. The
GPCRDB offers a BLAST service that allows users to
BLAST their sequence against the sequences in the
GPCRDB.
All search options and the BLAST services are available
via the web interface and as web services. A full SQL
search facility will be made available in the near future
to allow for complex queries and analyses.
Inferences
The amount of available GPCR related data is too large
for a human to grasp and disseminate. The GPCRDB
contains a series of inference engines that determine inter-
esting correlations between the data, while a series of
software tools help the user with data reduction and
abstraction.
Building alignments. The GPCRDB offers the possibility
to create custom-made alignments. The alignments are
created by using the procedure that is used for the
parent GPCR families as discussed earlier. Users can
select the proteins and residue positions that should be
aligned, allowing for the creation of e.g. an alignment of
all binding pocket residues for a selection of proteins
(Figure 7). The custom-built alignments are available for
download and users can directly interact with the align-
ments using JalView.
Figure 6. The protein search page.
Figure 7. A list of proteins and an optional list of residue positions can
be used to generate custom alignments. In this ﬁgure we have selected a
number of proteins for which crystal structures are available. The
GPCR-binding pocket residue positions as proposed by Gloriam
et al. (42) are used. The result will be an alignment of all pocket
residues of the selected proteins.
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create a service where users can predict the effects of a
point mutation. As for now, predictions are mainly
based on human knowledge that is stored in a computer
readable format. This information is combined with a
number of simple analyses on a homology model of the
receptor being mutated, such as looking for steric clashes
and helix disruptions. Results are presented as text-
fragments that explain the effects of the mutation on
the structure. Care has been taken to ensure that the
results are presented in a life scientist friendly manner.
The text contains references to literature and is enriched
with ﬁgures and animations of the mutation and its
surrounding environment. In the near future more intelli-
gence will be added to the software, such as incorporating
the quantitative data from the mutations extracted from
literature and ligand-binding information.
Analysis of entropy derived patterns. We offer a page
where users can interactively analyze the protein family
alignments (Figure 2). Plots displaying entropy and vari-
ability scores are displayed with a 3D model and a MSA.
Residues are linked in the three page elements, so that
clicking on a residue position in the multiple sequence
alignment will highlight the residue position in the struc-
ture as well as in the entropy and variability plots. This
offers researchers a very intuitive way of looking at
conservation scores, even at the subfamily or receptor
level, and relating those scores to the 3D structure. In
combination with above mentioned accessible data site
directed mutagenesis candidate selection, homology
modeling and ligand-binding hypotheses generation can
be performed.
Annotating scientiﬁc literature. We have developed a new
interface for the GPCR data in the form of a
GPCR-speciﬁc PDF reader (manuscript in preparation).
This reader can annotate scientiﬁc literature on GPCRs on
the ﬂy, providing users with context sensitive data from
the GPCRDB (Figure 8). This software is available upon
request and will be made freely available at the day of
publication of this article.
IMPLEMENTATION
The data in the GPCRDB is stored in a PostgreSQL
(http://www.postgresql.org/) relational database. The
web service interface is developed with the Apache CXF
Figure 8. An impression of the PDF reader [Utopia Documents (43), Utopia Documents-GPCRDB (in preparation)] interface to the GPCRDB
data. On the left side (A) a scientiﬁc paper (44) is shown that is annotated by the GPCRDB. Annotations are available for all the highlighted words.
On the right side (B) an example of such an annotation (the mutation F339L) is displayed. A short, manually extracted description of the effects of
this mutation is included (C).
Nucleic Acids Research, 2011,Vol.39, Database issue D317(http://cxf.apache.org/) web services framework. We offer
both SOAP and REST endpoints. The web interface is
built using the Apache Wicket (http://wicket.apache.org/)
web application framework. The database is accessed via a
Hibernate (http://www.hibernate.org) object-relational
mapping layer. The server is running within Sun’s
Glassﬁsh (http://glassﬁsh.org) application server.
FUTURE DIRECTIONS
In the near future we would like to extend the interactive
facilities of the GPCRDB by offering users more tools to
analyze the available data. The entropy-variability
analysis pages are a good example of the types of
services we will be offering. In addition to our main
focus of data collection and integration we would like to
extend our focus towards the more challenging ﬁeld of
knowledge integration. The mutation effect predictor is
a pilot project to explore the things we can do by
combining human expertise with computational power.
We are in the process of transforming the GPCRDB
from mainly a one-stop resource for GPCRDB data to a
place where scientists can use tools to interact with the
data and make predictions.
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